The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Pancreatic β-Cell Survival Is Dependent upon Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (PKB) Signaling, Inactivation of the Forkhead Transcription Factor Foxo1, and Down-regulation of bax Expression
Open accessAbstract
The hormone glucose-dependent insulinotropic polypeptide (GIP) potently stimulates insulin secretion and promotes beta-cell proliferation and cell survival. In the present study we identified Forkhead (Foxo1)-mediated suppression of the bax gene as a critical component of the effects of GIP on cell survival. Treatment of INS-1(832/13) beta-cells with GIP resulted in concentration-dependent activation of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB)/Foxo1 signaling module. In parallel studies, GIP decreased bax promoter activity. Serial deletion analysis of the bax promoter demonstrated that the region -682 to -320, containing FHRE-II (5AAAACAAACA), was responsible for GIP-mediated effects. Foxo1 bound to FHRE-II in gel mobility shift assays, and Foxo1-FHRE-II interactions conferred GIP responsiveness to the bax promoter. INS-1 cells incubated under proapoptotic and glucolipotoxic conditions demonstrated increased nuclear localization of Foxo1 and bax promoter activity and decreased cytoplasmic phospho-PKB/Foxo1. GIP partially restored expression PKB/Foxo1 and bax promoter activity. Similar protective effects were found with dispersed islet cells from C57BL/6 mice, but not with those from GIP receptor knock-out (GIPR(-/-)) mice. GIP treatment reduced glucolipotoxicity-induced cell death in C57 BL/6 and Bax(-/-) islets, but not GIPR(-/-) mouse islets. Chronic treatment of Vancouver diabetic fatty Zucker rats with GIP resulted in down-regulation of Bax and up-regulation of Bcl-2 in pancreatic beta-cells. The results show that PI3K/PKB/Foxo1 signaling mediates GIP suppression of bax gene expression and that this module is a key pathway by which GIP regulates beta-cell apoptosis in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Redox Regulation of Forkhead Proteins Through a p66shc -Dependent Signaling Pathway
Nemoto, S., & Finkel, T. (2002) · Science · doi:10.1126/science.1069004 · Cited by 818
Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats
Farilla, L., Hui, H., Bertolotto, C., Kang, E., Bulotta, A., Di Mario, U., & Perfetti, R. (2002) · Endocrinology · doi:10.1210/en.2002-220405 · Cited by 502
Miyawaki, K., Yamada, Y., Yano, H., Niwa, H., Ban, N., Ihara, Y., Kubota, A., Fujimoto, S., Kajikawa, M., Kuroe, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14843 · Cited by 454
Research works printed but not linked: 35
- Brunet, 2001, Curr. Opin. Neurobiol., 11, 297, 10.1016/S0959-4388(00)00211-7 · DOI · Paper page
- Franke, 1997, Cell, 88, 435, 10.1016/S0092-8674(00)81883-8 · DOI · Paper page
- Cardone, 1998, Science, 282, 1318, 10.1126/science.282.5392.1318 · DOI · Paper page
- Datta, 1997, Cell, 91, 231, 10.1016/S0092-8674(00)80405-5 · DOI · Paper page
- Pap, 1998, J. Biol. Chem., 273, 19929, 10.1074/jbc.273.32.19929 · DOI · Paper page
- Brunet, 1999, Cell, 96, 857, 10.1016/S0092-8674(00)80595-4 · DOI · Paper page
- Kaestner, 2000, Genes Dev., 14, 142, 10.1101/gad.14.2.142 · DOI · Paper page
- Arden, 2002, Arch. Biochem. Biophys., 403, 292, 10.1016/S0003-9861(02)00207-2 · DOI
- Rena, 2002, EMBO J., 21, 2263, 10.1093/emboj/21.9.2263 · DOI · Paper page
- Kops, 2002, Mol. Cell. Biol., 22, 2025, 10.1128/MCB.22.7.2025-2036.2002 · DOI · Paper page
- Tran, 2002, Science, 296, 530, 10.1126/science.1068712 · DOI · Paper page
- Webster, 2004, Circ. Res., 94, 856, 10.1161/01.RES.0000126699.49835.5D · DOI
- Kieffer, 1999, Endocr. Rev., 20, 876, 10.1210/edrv.20.6.0385 · DOI · Paper page
- Drucker, 2003, Mol. Endocrinol., 17, 161, 10.1210/me.2002-0306 · DOI · Paper page
- Trümper, 2002, J. Endocrinol., 174, 233, 10.1677/joe.0.1740233 · DOI · Paper page
- Ehses, 2003, Endocrinology, 144, 4433, 10.1210/en.2002-0068 · DOI · Paper page
- Trümper, 2001, Mol. Endocrinol., 15, 1559
- Knudsen, 1995, Science, 270, 96, 10.1126/science.270.5233.96 · DOI · Paper page
- MacDonald, 2001, Mol. Endocrinol., 15, 1423, 10.1210/mend.15.8.0685 · doi:10.1210/mend.15.8.0685 · Paper page
- Alessi, 1996, EMBO J., 5, 6541, 10.1002/j.1460-2075.1996.tb01045.x · DOI · Paper page
- Prentki, 2002, Diabetes, 51, S405, 10.2337/diabetes.51.2007.S405 · DOI · Paper page
- Winter, 2004, Diabetes, 53, A447
- Nakae, 2002, Nat. Gen., 32, 245, 10.1038/ng890 · DOI · Paper page
- Kitamura, 2002, J. Clin. Investig., 110, 1839, 10.1172/JCI200216857 · DOI
- Accili, 2004, Diabetes, 53, 1633, 10.2337/diabetes.53.7.1633 · DOI · Paper page
- Yamauchi, 2001, J. Biol. Chem., 276, 23362, 10.1074/jbc.M011752200 · DOI
- Cheung, 2004, J. Biol. Chem., 279, 45308, 10.1074/jbc.C400333200 · DOI
- Uhlik, 2003, Nat. Cell Biol., 5, 1104, 10.1038/ncb1071 · DOI · Paper page
- Kilic, 2002, Cell Death Differ., 9, 125, 10.1038/sj.cdd.4400968 · DOI
- Schamberger, 2005, Exp. Cell Res., 302, 115, 10.1016/j.yexcr.2004.08.026 · doi:10.1016/j.yexcr.2004.08.026
- Unger, 2001, Diabetes, 50, S118, 10.2337/diabetes.50.2007.S118 · DOI · Paper page
- Kharroubi, 2004, Endocrinology, 145, 5087, 10.1210/en.2004-0478 · DOI · Paper page
- Maestre, 2003, Endocrinology, 144, 335, 10.1210/en.2001-211282 · DOI · Paper page
- Hui, 2004, J. Cell. Physiol., 200, 177, 10.1002/jcp.20021 · DOI
- Adams, 1998, Science, 281, 1322, 10.1126/science.281.5381.1322 · DOI · Paper page
Cited by
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“223,224 GLP-1 also inhibits glucagon release from α -cells, which is bene fi cial for reducing blood glucose levels since glucagon promotes hepatic gluconeogenesis.”
BackgroundThe role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
“In particular, GIP phosphorylates several transcription factors such as FoxO1 and p70S6K, crucial regulators of translation known to be involved in glucose-induced -cell mitogenesis, suggesting possible mediators of GIP-mediated -cell growth (Ehses et al., 2002).”
BackgroundResultInfluentialGIP and GLP-1, the two incretin hormones: Similarities and differences
Seino, Y., Fukushima, M., & Yabe, D. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00022.x · Cited by 746
The role of gut hormones in glucose homeostasis
Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30076 · Cited by 614
The multiple functions and mechanisms of osteopontin
Icer, M. A., & Gezmen-Karadag, M. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.07.003 · Cited by 606
Recent advances in understanding the anti-diabetic actions of dietary flavonoids
Babu, P. V. A., Liu, D., & Gilbert, E. R. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.06.003 · Cited by 544
The role of FoxO in the regulation of metabolism
Gross, D. N., van den Heuvel, A. P. J., & Birnbaum, M. J. (2008) · Oncogene · doi:10.1038/onc.2008.25 · Cited by 540
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids
Kawser Hossain, M., Abdal Dayem, A., Han, J., Yin, Y., Kim, K., Kumar Saha, S., Yang, G.-M., Choi, H., & Cho, S.-G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040569 · Cited by 495
Shu, L., Matveyenko, A. V., Kerr-Conte, J., Cho, J.-H., McIntosh, C. H. S., & Maedler, K. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp178 · Cited by 270
Self-citationMechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Liu, Q. K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1431292 · Cited by 265
Hurley, R. L., Barré, L. K., Wood, S. D., Anderson, K. A., Kemp, B. E., Means, A. R., & Witters, L. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606676200 · Cited by 263
Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609088200 · Cited by 216
Self-citationTranscription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic β-cell mass
Buteau, J., Spatz, M. L., & Accili, D. (2006) · Diabetes · doi:10.2337/db05-0825 · Cited by 178
“Moreover, a recent publication demonstrates that FoxO1 mediates the action of glucose-dependent inhibitory peptide on -cell survival by regulating Bax expression (35).”
BackgroundThe emerging role of FOXO transcription factors in pancreatic β cells
Glauser, D. A., & Schlegel, W. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0191 · Cited by 153
TCF1 links GIPR signaling to the control of beta cell function and survival
Campbell, J. E., Ussher, J. R., Mulvihill, E. E., Kolic, J., Baggio, L. L., Cao, X., Liu, Y., Lamont, B. J., Morii, T., Streutker, C. J., et al. (2016) · Nature Medicine · doi:10.1038/nm.3997 · Cited by 142
Song, D. H., Getty–Kaushik, L., Tseng, E., Simon, J., Corkey, B. E., & Wolfe, M. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.005 · Cited by 137
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006841 · Cited by 133
Self-citationPiteau, S., Olver, A., Kim, S.-J., Winter, K., Pospisilik, J. A., Lynn, F., Manhart, S., Demuth, H.-U., Speck, M., Pederson, R. A., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.115 · Cited by 130
Self-citationSitagliptin Prevents Inflammation and Apoptotic Cell Death in the Kidney of Type 2 Diabetic Animals
Marques, C., Mega, C., Gonçalves, A., Rodrigues-Santos, P., Teixeira-Lemos, E., Teixeira, F., Fontes-Ribeiro, C., Reis, F., & Fernandes, R. (2014) · Mediators of Inflammation · doi:10.1155/2014/538737 · Cited by 126
Incretins: their physiology and application in the treatment of diabetes mellitus
Tasyurek, H. M., Altunbas, H. A., Balci, M. K., & Sanlioglu, S. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2501 · Cited by 121
“Just like GLP-1, GIP manifested both proliferative and anti-apoptotic effects on pancreatic beta cells [42,43]. incretin peptide antagonists in various species including humans (Table 1).”
BackgroundKim, S.-J., Nian, C., & McIntosh, C. H. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704896200 · Cited by 118
Self-citationGlucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease
Heimbürger, S. M., Bergmann, N. C., Augustin, R., Gasbjerg, L. S., Christensen, M. B., & Knop, F. K. (2020) · Peptides · doi:10.1016/j.peptides.2019.170174 · Cited by 67
GIP reduces osteoclast activity and improves osteoblast survival in primary human bone cells
Hansen, M. S., Søe, K., Christensen, L. L., Fernandez-Guerra, P., Hansen, N. W., Wyatt, R. A., Martin, C., Hardy, R. S., Andersen, T. L., Olesen, J. B., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvac004 · Cited by 62
Liu, T., Ji, R.-L., & Tao, Y.-X. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108044 · Cited by 34
Effects on pancreatic Beta and other Islet cells of the glucose-dependent insulinotropic polypeptide
Khan, R., Tomas, A., & Rutter, G. A. (2020) · Peptides · doi:10.1016/j.peptides.2019.170201 · Cited by 24
Metadata
- Authors
- Kim, S.-J., Winter, K., Nian, C., Tsuneoka, M., Koda, Y., & McIntosh, C. H. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 280
- Issue
- 23
- Pages
- 22297-22307
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2074519205
- Cited by
- 241
- References
- 5
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5616 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.